Early diabetes treatment linked to better survival in Korean health study

A large Korean cohort study has added weight to an enduring clinical intuition: that the window between a diabetes diagnosis and the start of treatment is not merely administrative, but biological. Tracking more than 23,000 people over five years, researchers found that those who began medication within months of crossing the diagnostic threshold were meaningfully more likely to be alive at the study's end — a quiet reminder that timing, in medicine as in life, carries its own moral weight. The cardiovascular picture remains unresolved, and the populations studied were not fully representative